NASHVILLE — The quiet hum of equipment underscored the lab as Dr. Mark Denison and his colleagues got to work at Vanderbilt University Medical Center on an early October morning.
Denison wove between benches full of pipettes, centrifuges and microscopes while he talked about their research into a promising antiviral drug that could dramatically reduce severe cases of COVID-19 and prevent hospitalizations.
